{"id":3892,"date":"2022-04-22T10:25:22","date_gmt":"2022-04-22T14:25:22","guid":{"rendered":"https:\/\/a4pc.org\/?p=3892"},"modified":"2022-04-29T10:30:01","modified_gmt":"2022-04-29T14:30:01","slug":"compounding-connections-april-22-2022","status":"publish","type":"post","link":"https:\/\/whizkid.com\/a4pc\/2022-04\/compounding-connections-april-22-2022\/","title":{"rendered":"CC: April 22, 2022"},"content":{"rendered":"

<\/p>\n

[[trackingImage]]<\/span><\/p>\n

<\/p>\n

\n

\"Masthead\" <\/p>\n

The voice for pharmacy compounding | April 22, 2022<\/p>\n<\/div>\n

<\/p>\n

\n

\"Our<\/a><\/p>\n<\/div>\n

<\/p>\n

\n

From APC\u2019s President<\/h1>\n

Our undervalued resource<\/h2>\n


\nDavid J. Miller, RPh
\nAPC President<\/span><\/p>\n

One of the things that bothers me is when I meet someone at a pharmacy conference and ask what they do and they say, \u201cOh, I\u2019m just a technician.\u201d<\/p>\n

WHAT?! JUST a technician? I\u2019ve always valued my technicians as equal to every other team member. They have an equal status with my pharmacists. Why? Because no pharmacy could function without them<\/em>. They are critical to our profession.<\/p>\n

I had three goals when I assumed the presidency of APC: membership, fellowship, and elevation of the status of technicians. Membership is on its way \u2014 we\u2019ve gained 1,200 new members already this year thanks to PFM (and most of them are technicians!). And as you\u2019ll soon hear, the APC Fellows Program is back on track. So now we can focus on technician elevation.<\/p>\n

Early this year, I formed a new technician committee to examine and implement ways to elevate the status of pharmacy technicians. The committee, co-chaired by Erin Michaels and Stephanie Chacon, has met three times for active discussions about some great ideas, such as technician-specific continuing education programs and technician-specific mixers at events. (And when we learned that in-person CompPAC events were beyond the financial reach of most technicians, I worked with the CompPAC committee to lower the registration fee from $1,000 to $250 for technicians.)<\/p>\n

This is just the beginning. Technicians: Tell us what APC can do for you! We need to hear from you.<\/em> If you have ideas for programs or services, please contact Erin at EMichael@pccarx.com<\/a> or Stephanie at schacon@empowerpharmacy.com<\/a>. They would love to hear from you and bring your ideas to the alliance.<\/p>\n

Because you\u2019re not<\/em> just a technician. You\u2019re the backbone of our practice.<\/p>\n

\"\"<\/a><\/p>\n

<\/p>\n

\n

David Miller<\/strong> is APC\u2019s president and the managing co-owner of Keystone Compounding Pharmacy in Grand Rapids, Michigan. You can reach him at drdave@keystonepharm.com<\/a>.<\/p>\n<\/div>\n

<\/p>\n

This Week<\/h1>\n

<\/p>\n

Finally: a patient-reported outcomes platform for\u00a0compounding<\/h2>\n

Big news for APC Pharmacy-Facility Members: You now have access to a great new compounding-specific patient-reported outcomes tool<\/strong>: OutcomeMD.<\/p>\n

\"\"<\/a><\/p>\n

It\u2019s an outcome-tracking and marketing platform \u2014 an extraordinary strategic tool for the compounding profession and<\/em> a great business solution for individual pharmacies.<\/p>\n

Why it matters<\/h4>\n

There\u2019s plenty of anecdotal evidence for positive patient outcomes, but not enough of the validated, standardized data FDA wants to see. The OutcomeMD platform will help change that, allowing APC to aggregate patient-reported outcome data while providing compounding pharmacy owners granular data on how their formulations are working for patients.<\/p>\n

\u201cThe OutcomeMD platform is something long-needed in compounding: A means of collecting and aggregating patient outcomes data in a way that\u2019s not just useful to the pharmacy but useful to the profession,\u201d said APC\u2019s CEO Scott Brunner, CAE.<\/strong><\/p>\n

Via a smartphone app, patients respond to questions about how their specific therapies are working. Owners in turn get data about those formulations using the same validated measures used in clinical trials (and that FDA uses in its database). And, with the owners\u2019 permission, APC gets access to the aggregated metadata \u2014 scrubbed of HIPAA-protected details, of course \u2014 to share with FDA and demonstrate how patients benefit from compounded therapies.<\/p>\n

Benefits to your pharmacy<\/h4>\n

Using OutcomeMD also provides direct benefits to you and your patients.<\/p>\n